| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.ATV.14.11.1705 |
| P698 | PubMed publication ID | 7947593 |
| P2093 | author name string | L M Havekes | |
| R R Frants | |||
| A Van Tol | |||
| J A Gevers Leuven | |||
| A Van der Laarse | |||
| S P Zhao | |||
| A H Smelt | |||
| A M Van den Maagdenberg | |||
| F M Van 't Hooft | |||
| T F Vroom | |||
| P433 | issue | 11 | |
| P921 | main subject | simvastatin | Q670131 |
| familial dysbetalipoproteinemia | Q2069207 | ||
| P304 | page(s) | 1705-1716 | |
| P577 | publication date | 1994-11-01 | |
| P1433 | published in | Arteriosclerosis and thrombosis : a journal of vascular biology | Q27709770 |
| P1476 | title | Plasma lipoproteins in familial dysbetalipoproteinemia associated with apolipoproteins E2(Arg158-->Cys), E3-Leiden, and E2(Lys146-->Gln), and effects of treatment with simvastatin | |
| P478 | volume | 14 |
| Q73224138 | Coexisting dysbetalipoproteinemia and familial hypercholesterolemia. Clinical and laboratory observations |
| Q77933882 | Comparison of the hypolipidemic effect of gemfibrozil versus simvastatin in patients with type III hyperlipoproteinemia |
| Q46945180 | Effect of adding bezafibrate to standard lipid-lowering therapy on post-fat load lipid levels in patients with familial dysbetalipoproteinemia. A randomized placebo-controlled crossover trial. |
| Q45948223 | Hypolipidemic and hyperlipidemic phenotypes in transgenic mice expressing human apolipoprotein E2. |
| Q35580326 | Long term efficacy and safety of atorvastatin in the treatment of severe type III and combined dyslipidaemia |
| Q37067797 | Statins as effectors of key activities involved in apoE-dependent VLDL metabolism: review and hypothesis |
| Q44983298 | Time-dependent lipid response on fluvastatin therapy of patients with hypercholesterolemia sensitive to apoE phenotype. |
Search more.